TransMedics Group, Inc. (TMDX) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Transmedics third quarter 2025 earnings conference call. At this time, all participants are in the listen-only mode. We will be facilitating a question and answer session towards the end of today's call. As a reminder, this call is being recorded for replay purposes. If you require operator assistance, please press star and then zero. I would now like to turn the call over to Ms. Lane Morgan from Gilmartin Group for a few introductory remarks. Thank you. Thank you. Earlier today, Transmedics released financial results for the quarter ended September 30th, 2025. A copy of the press release is available on the company's website. Before we begin, I would like to remind you that management will make statements during this call, including during the question and answer portion of the call, that include forward-looking statements within the meaning of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. These four looking statements address various matters, including, among other things, future events, results, and performance, financial guidance, and projected expectations, potential market and business conditions, our examination of operating trends, the potential commercial opportunity for our products and services, the potential timing, outcome, and impact of new clinical programs, and our potential initiatives, opportunities, and plans in the U.S. and globally, including timing and expectations. These statements involve risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by the forward-looking statements. Accordingly, you should not place und...